dichloro(1,2-bis(4-hydroxyphenyl)ethylenediamine)platinum ii has been researched along with Breast Cancer in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (25.00) | 18.7374 |
| 1990's | 3 (75.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Berger, M; Engel, J; Jennerwein, M; Schönenberger, H; von Angerer, E; Wappes, B; Wrobel, KH | 1 |
| Bednarski, PJ; Eggers, H; Kratochwil, NA; Otto, AM | 1 |
| Holler, E; Koop, R; Meyer, T; Schönenberger, H; von Angerer, E | 1 |
| Faderl, M; Otto, AM; Schönenberger, H | 1 |
4 other study(ies) available for dichloro(1,2-bis(4-hydroxyphenyl)ethylenediamine)platinum ii and Breast Cancer
| Article | Year |
|---|---|
Dichloro[1,2-bis(4-hydroxyphenyl)ethylenediamine]platinum(II) complexes: an approach to develop compounds with a specific effect on the hormone-dependent mammary carcinoma.
Topics: Animals; Antineoplastic Agents; Breast Neoplasms; Cell Line; Drug Evaluation, Preclinical; Estradiol; Female; Humans; Indicators and Reagents; Leukemia, Experimental; Mice; Mice, Inbred BALB C; Molecular Conformation; Organoplatinum Compounds; Plasmacytoma; Rats; Rats, Inbred Strains; Receptors, Estradiol; Structure-Activity Relationship | 1984 |
Chemical stability, biological activity and cellular uptake of a cisplatin analogue having a 1,2-diarylethyleneamine ligand in cultures of human breast cancer cells.
Topics: Antineoplastic Agents; Blood Proteins; Breast Neoplasms; Cell Count; Chromatography, High Pressure Liquid; Culture Media; DNA; Drug Stability; Humans; Organoplatinum Compounds; Receptors, Estrogen; Tumor Cells, Cultured | 1995 |
A rapid luciferase transfection assay for transcription activation effects and stability control of estrogenic drugs in cell cultures.
Topics: Antineoplastic Agents; Breast Neoplasms; Enzyme Activation; Estradiol; Estrogens, Non-Steroidal; Female; Humans; Luciferases; Organoplatinum Compounds; Receptors, Estrogen; Transcription, Genetic; Transfection; Tumor Cells, Cultured | 1994 |
Dissociation of estrogenic and cytotoxic properties of an estrogen receptor-binding platinum complex in human breast cancer cell lines.
Topics: Antineoplastic Agents; Breast Neoplasms; Cell Division; Cell Line; Cell Survival; Dose-Response Relationship, Drug; Estradiol; Female; Humans; Kinetics; Organoplatinum Compounds; Receptors, Estrogen; Receptors, Progesterone | 1991 |